While much of our externally visible efforts are to prepare for the launch of CeQur Simplicity™, our team of medical, design, and manufacturing professionals remain dedicated to the launch of our pipeline. We will continue to provide updates on this progress through our press releases and email communications. The sections below provide more details of products under development.
This device is not yet cleared for use in the United States.
A simple 3-day wearable basal-bolus insulin device.
— Significantly improved glycemic control among people with type 2 diabetes
— Participants reported increased treatment satisfaction with CeQur PAQ versus insulin injections
CeQur PAQ device in development is a wearable insulin delivery device that delivers up to 3 days of continuous pre-set basal insulin plus on-demand mealtime bolus in 2 unit increments.
CeQur PAQ has two components:
To receive updates about this product, please join our mailing list, below.
Findings from a studies evaluating the company’s CeQur PAQ Insulin Delivery Device among people with type 2 diabetes. The data demonstrate that the simple, three-day, wearable basal-bolus insulin delivery device significantly improved glycemic control among people with type 2 diabetes who transitioned to the device. Study participants also reported increased treatment satisfaction with the device as compared to insulin injections.
The HbA1c (commonly called A1C) is an average of what your blood sugar levels have been over the past three months. In general, the higher your A1C number, the higher your risk for diabetes complications. (A high A1C means there is too much sugar in your blood and your body isn’t absorbing it.)
Your body uses insulin to allow sugar to enter into your cells. Diabetes is very complicated, but essentially the cells of your body are not properly fed which can lead to complications. Insulin has been used for over 90 years as a life-saving treatment for people with diabetes. While many advancements have been made over the years regarding the types of insulin and how it has been administered, there are basically two modes of use – basal and bolus. Basal is the small amounts of insulin that your body needs all day long, even while you are asleep. Even when you don’t eat (fasting) your body is still releasing sugar into your blood, mostly stored and released by your liver. Bolus insulin is a short-term dose needed at mealtime to help your body absorb the increase in blood sugar that occurs when you eat. For some patients a basal and bolus insulin is needed to manage blood sugar levels all day long. How well you manage your blood sugar levels each day determines your A1C score, since it is an average of the past 90 days.
Insulin is a protein molecule produced in your pancreas. Different types of insulin are now produced in a variety of ways to provide insulin for people whose bodies don’t produce enough or any insulin. Since it is a protein, insulin cannot be taken orally because it would be digested in your stomach the same way other proteins that you eat are digested. Therefore, insulin must be injected into your body to enter your bloodstream. This requires needles or other methods for dosing. CeQur understands that needles and devices can add to the complexities of managing your diabetes, so our mission is to make insulin therapy simpler, more convenient, effective and safe.
* Humalog® is a registered trademark of Eli Lilly and Company. NovoLog® is a registered trademark of Novo Nordisk A/S.